KOD RSI Chart
Last 7 days
-2.5%
Last 30 days
-12.9%
Last 90 days
-20.8%
Trailing 12 Months
-17.9%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Jun 16, 2023 | ehrlich jason | sold | -20,841 | 9.23 | -2,258 | see remarks |
Jun 16, 2023 | borgeson john a. | sold | -25,373 | 9.23 | -2,749 | see remarks |
Jun 15, 2023 | borgeson john a. | acquired | - | - | 5,494 | see remarks |
Jun 15, 2023 | ehrlich jason | acquired | - | - | 5,494 | see remarks |
Jun 14, 2023 | ehrlich jason | sold | -10,663 | 9.42 | -1,132 | see remarks |
Jun 14, 2023 | borgeson john a. | sold | -13,640 | 9.42 | -1,448 | see remarks |
Jun 11, 2023 | ehrlich jason | acquired | - | - | 2,900 | see remarks |
Jun 11, 2023 | borgeson john a. | acquired | - | - | 3,025 | see remarks |
Dec 30, 2022 | perlroth victor | gifted | - | - | -60,000 | chairman and ceo |
Jun 17, 2022 | ehrlich jason | sold | -16,019 | 7.02 | -2,282 | see remarks |
Which funds bought or sold KOD recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 13, 2024 | Nuveen Asset Management, LLC | unchanged | - | 322,897 | 765,062 | -% |
May 13, 2024 | STRS OHIO | reduced | -15.29 | 48,000 | 151,000 | -% |
May 13, 2024 | Financial Gravity Asset Management, Inc. | sold off | - | - | 1.00 | -% |
May 13, 2024 | Continuum Advisory, LLC | added | 7.22 | 14,328 | 56,438 | 0.01% |
May 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | added | 2.08 | 1,649,920 | 3,803,210 | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | reduced | -6.27 | 1,172,000 | 3,058,000 | -% |
May 13, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.86 | 35,065 | 84,076 | -% |
May 13, 2024 | FRANKLIN RESOURCES INC | new | - | 170,219 | 170,219 | -% |
May 13, 2024 | Ameritas Investment Partners, Inc. | unchanged | - | 5,701 | 13,508 | -% |
May 13, 2024 | HRT FINANCIAL LP | sold off | -100 | -138,000 | - | -% |
Unveiling Kodiak Sciences Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Kodiak Sciences Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 49.2B | 6.8B | -8.24 | 7.18 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.7B | 2.0B | -56.37 | 9.34 | ||||
BMRN | 15.1B | 2.5B | 73.61 | 6.12 | ||||
INCY | 12.8B | 3.8B | 17.19 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.93 | 48.09 | ||||
APLS | 5.2B | 524.1M | -12.51 | 9.96 | ||||
AXSM | 3.7B | 251.0M | -12.4 | 14.64 | ||||
ARWR | 2.8B | 240.7M | -6.04 | 12.77 | ||||
ACAD | 2.5B | 813.8M | -1.4K | 3.01 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.9B | 996.6M | -4.75 | 1.9 | ||||
CRBP | 456.3M | 881.7K | -13.52 | 481.06 | ||||
INO | 297.2M | 4.9M | -2.38 | 61.07 | ||||
IBIO | 16.2M | 2.1M | -0.7 | 7.61 |
Kodiak Sciences Inc News
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -12.5% | 479 | 548 | 590 | 640 | 667 | 724 | 782 | 850 | 904 | 958 | 998 | 1,033 | 1,067 | 481 | 429 | 443 | 359 | 69.00 | 78.00 | 87.00 | 92.00 |
Current Assets | -17.6% | 289 | 351 | 387 | 431 | 486 | 545 | 604 | 682 | 735 | 806 | 884 | 932 | 972 | 382 | 419 | 425 | 339 | 61.00 | 70.00 | 83.00 | 90.00 |
Cash Equivalents | -17.4% | 286 | 346 | 379 | 317 | 190 | 178 | 173 | 672 | 732 | 799 | 881 | 920 | 944 | 292 | 270 | 226 | 212 | 37.00 | 45.00 | 57.00 | 88.00 |
Net PPE | -3.8% | 120 | 125 | 130 | 135 | 56.00 | 56.00 | 55.00 | 49.00 | 41.00 | 23.00 | 9.00 | 7.00 | 5.00 | 4.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Liabilities | -12.9% | 214 | 245 | 251 | 248 | 230 | 244 | 251 | 253 | 241 | 232 | 218 | 211 | 207 | 199 | 120 | 115 | 14.00 | 9.00 | 8.00 | 7.00 | 5.00 |
Current Liabilities | -41.0% | 42.00 | 71.00 | 74.00 | 69.00 | 52.00 | 66.00 | 70.00 | 76.00 | 65.00 | 54.00 | 41.00 | 35.00 | 31.00 | 23.00 | 19.00 | 14.00 | 12.00 | 7.00 | 6.00 | 5.00 | 5.00 |
Shareholder's Equity | -12.1% | 266 | 302 | 338 | 393 | 436 | 480 | 531 | 597 | 663 | 726 | 779 | 822 | 861 | 282 | 309 | 328 | 345 | 60.00 | 70.00 | 80.00 | 87.00 |
Retained Earnings | -5.4% | -1,152 | -1,093 | -1,043 | -962 | -892 | -821 | -744 | -653 | -558 | -465 | -397 | -341 | -291 | -244 | -208 | -182 | -158 | -142 | -130 | -118 | -110 |
Additional Paid-In Capital | 1.6% | 1,418 | 1,395 | 1,381 | 1,355 | 1,330 | 1,304 | 1,277 | 1,251 | 1,222 | 1,191 | 1,177 | 1,163 | 1,152 | 526 | 517 | 510 | 503 | 202 | 200 | 199 | 198 |
Shares Outstanding | 0.1% | 53.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | 52.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 222 | - | - | - | 243 | - | - | - | 3,100 | - | - | - | 1,600 | - | - | - | 274 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 1.6% | -32,239 | -32,764 | -41,959 | -47,221 | -55,075 | -53,087 | -55,137 | -43,160 | -59,035 | -51,949 | -36,661 | -34,625 | -27,019 | -24,572 | -13,905 | -17,932 | -11,293 | -7,696 | -12,950 | -7,207 | -8,340 |
Share Based Compensation | 63.7% | 22,829 | 13,946 | 25,801 | 25,980 | 25,778 | 26,182 | 25,978 | 28,095 | 27,996 | 12,377 | 11,087 | 9,925 | 9,455 | 8,241 | 6,890 | 6,082 | 1,936 | 1,773 | 1,244 | 1,157 | 1,116 |
Cashflow From Investing | -12200.0% | -27,798 | -226 | 103,844 | 173,406 | 66,998 | 58,730 | -443,952 | -18,289 | -10,859 | -31,705 | -5,452 | 9,218 | 58,858 | 56,392 | 56,781 | -67,197 | -113,283 | -523 | 680 | -23,872 | -525 |
Cashflow From Financing | -933.3% | -124 | -12.00 | 170 | -3.00 | 97.00 | 78.00 | 54.00 | 1,666 | 2,157 | 2,031 | 2,522 | 1,472 | 616,281 | 804 | 504 | 99,788 | 299,340 | 285 | 15.00 | 47.00 | 85,529 |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating expenses | |||
Research and development | $ 206,298 | $ 267,591 | $ 217,340 |
General and administrative | 71,023 | 73,788 | 49,711 |
Total operating expenses | 277,321 | 341,379 | 267,051 |
Loss from operations | (277,321) | (341,379) | (267,051) |
Interest income | 16,733 | 7,071 | 298 |
Interest expense | (13) | (18) | (47) |
Other income (expense), net | 110 | 503 | (190) |
Net loss | $ (260,491) | $ (333,823) | $ (266,990) |
Net loss per share common share, basic | $ (4.97) | $ (6.39) | $ (5.16) |
Net loss per share common share, diluted | $ (4.97) | $ (6.39) | $ (5.16) |
Weighted-average shares of common stock outstanding used in computing net loss per common share, basic | 52,414,256 | 52,249,620 | 51,788,918 |
Weighted-average shares of common stock outstanding used in computing net loss per common share, diluted | 52,414,256 | 52,249,620 | 51,788,918 |
Other comprehensive income (loss) | |||
Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax | $ 1,307 | $ (1,307) | $ (53) |
Total other comprehensive income (loss) | 1,307 | (1,307) | (53) |
Comprehensive loss | $ (259,184) | $ (335,130) | $ (267,043) |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 285,507 | $ 190,433 |
Marketable securities | 0 | 288,500 |
Prepaid expenses and other current assets | 3,802 | 7,072 |
Total current assets | 289,309 | 486,005 |
Restricted cash | 6,324 | 6,324 |
Property and equipment, net | 120,482 | 56,384 |
Operating lease right-of-use asset | 54,541 | 59,369 |
Other assets | 8,716 | 58,546 |
Total assets | 479,372 | 666,628 |
Current liabilities: | ||
Accounts payable | 13,608 | 9,130 |
Accrued and other current liabilities | 18,351 | 33,440 |
Operating lease liability | 9,770 | 9,926 |
Total current liabilities | 41,729 | 52,496 |
Operating lease liability, net of current portion | 71,862 | 77,807 |
Liability related to sale of future royalties | 100,000 | 99,996 |
Other liabilities | 0 | 162 |
Total liabilities | 213,591 | 230,461 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 0 | 0 |
Common stock, $0.0001 par value, 490,000,000 shares authorized at December 31, 2023 and December 31, 2022; 52,508,602 and 52,333,850 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 5 | 5 |
Additional paid-in capital | 1,418,307 | 1,329,509 |
Accumulated other comprehensive income (loss) | 0 | (1,307) |
Accumulated deficit | (1,152,531) | (892,040) |
Total stockholders’ equity | 265,781 | 436,167 |
Total liabilities and stockholders’ equity | $ 479,372 | $ 666,628 |